United States Ninth Circuit

In an antitrust action alleging monopoly leveraging in an HIV drug market, the denial of summary judgment to Defendants is reversed, where allegations of monopoly leveraging through pricing conduct in two markets does not state a claim under Section 2 of the Sherman Act absent an antitrust refusal to deal in the monopoly market or below-cost pricing in the second market.

Appellate Information

• Argued 05/13/2009
• Decided 07/07/2009
• Published 07/07/2009

Judges

• RYMER, Circuit Judge:, Before:  MARY M. SCHROEDER, STEPHEN REINHARDT and PAMELA ANN RYMER, Circuit Judges.

Court

• United States Ninth Circuit

Counsel

• For Appellees:
  
• James F. Hurst, Winston & Strawn LLP, Chicago, IL, (argued);  Jeffrey I. Weinberger, Munger, Tolles & Olson LLP, Los Angeles, CA, for the defendant-appellant., Richard R. Wiebe, Law Office of Richard R. Wiebe, San Francisco, CA, (argued);  Christopher T. Heffelfinger, Bermand DeValerio, San Francisco, CA, for plaintiffs-appellees John Doe 1, John Doe 2, and Individual Class Members., Michael W. Stocker, Labaton Sucharow LLP, New York, NY, for plaintiffs-appellees Service Employees International Union Health and Welfare Fund and for the Certified Class.